SCHEMBL10065161

SCHEMBL10065161

Brc1cccc2oc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
ATM Q13315 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAB9A P51151 5/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HIF1A Q16665 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 2/20 0.38
NPC1 O15118 5/20 0.37
HPGD P15428 3/20 0.36
CYP2D6 P10635 1/20 0.36
TOP2A P11388 2/20 0.36
TP53 P04637 1/20 0.35
PTPN1 P18031 6/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10065234 0.99 KDM4E (0.38) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL13426395 0.94 RAB9A (0.39) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL10065353 0.90 KDM4E (0.39) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL13426836 0.86 RAB9A (0.36) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL10065127 0.85 KDM4E (0.39) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL10065130 0.85 KDM4E (0.39) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL10065095 0.85 CEPT1 (0.45) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL10065120 0.85 KDM4E (0.39) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL10065098 0.84 TOP2A (0.47) KDM4EATML3MBTL1RAB9ASMN1; SMN2
SCHEMBL10065239 0.84 KDM4E (0.38) KDM4EATML3MBTL1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 US disclosed
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative GABRA1, GABRA4, GABRA5 KDM4E 3212/4885ATM 4083/4885L3MBTL1 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.